APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area
- PMID: 28461186
- DOI: 10.1016/j.brainresbull.2017.04.017
APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area
Abstract
Objective: This study aimed to investigate the impact of apolipoprotein E 4 (APOE4) gene polymorphisms on the expressions of inflammatory factors and the progression of Alzheimer's disease (AD).
Methods: A total of 185 AD patients (the case group, 130 cases from the Han ethnic group and 55 cases from the She ethnic group) and 190 healthy individuals (the control group, 130 cases from the Han ethnic group and 60 cases from the She ethnic group) were recruited for our study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was conducted to detect APOE4 genotype and allele frequency. Enzyme-linked immunosorbent assay (ELISA) was used to determine the expressions of inflammatory factors in plasma.
Results: In both Han and She populations, the frequency of ε3/4 and ε4/4 genotypes and the ε4 allele was significantly higher in the case group than that in the control group. ε3/4 and ε4/4 genotypes and the ε4 allele were the risk factors for AD. In both Han and She populations, the ε2/4, ε3/4 and ε4/4 carriers showed increased levels of TNF-α, IL-6, and IL-1β when compared with the ε2/2 + ε2/3 + ε3/3 carriers. The TNF-α, IL-6, and IL-1β levels were higher in the ε4/4 carriers than those in the ε2/4 and ε3/4 carriers, and ε2/4, ε3/4 and ε4/4 carriers in the case group exhibited increased levels of TNF-α, IL-6, and IL-1β when compared with the control group (P<0.05). Logistic regression analysis indicated that the ε3/4 genotype and TNF-α, IL-6, and IL-1β levels were associated with the susceptibility to AD in the Han population, while ε3/4 and ε4/4 genotypes and TNF-α, IL-6, and IL-1β levels were related to the susceptibility to AD in the She population.
Conclusions: The APOE4 ε4 allele may enhance susceptibility to AD and promotes the expressions of inflammatory factors in AD.
Keywords: Alzheimer's disease; Apolipoprotein E; Gene polymorphism; IL-6; IL-β; Inflammatory factor; TNF-α.
Copyright © 2017. Published by Elsevier Inc.
Similar articles
-
Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.Sci Rep. 2022 Aug 10;12(1):13620. doi: 10.1038/s41598-022-18033-x. Sci Rep. 2022. PMID: 35948759 Free PMC article.
-
Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations.Psychogeriatrics. 2012 Jun;12(2):83-7. doi: 10.1111/j.1479-8301.2011.00389.x. Psychogeriatrics. 2012. PMID: 22712640
-
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.JAMA. 1997 Oct 22-29;278(16):1349-56. JAMA. 1997. PMID: 9343467
-
Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):575-82. doi: 10.1177/1533317514531443. Am J Alzheimers Dis Other Demen. 2014. PMID: 25551132 Free PMC article. Review.
-
Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis.Epilepsy Behav. 2019 Sep;98(Pt A):27-35. doi: 10.1016/j.yebeh.2019.06.015. Epub 2019 Jul 9. Epilepsy Behav. 2019. PMID: 31299529
Cited by
-
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.Curr Atheroscler Rep. 2020 Jul 25;22(9):48. doi: 10.1007/s11883-020-00867-3. Curr Atheroscler Rep. 2020. PMID: 32710255 Free PMC article. Review.
-
Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy.Front Aging Neurosci. 2022 Apr 18;14:862362. doi: 10.3389/fnagi.2022.862362. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35517054 Free PMC article.
-
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease.J Neuroinflammation. 2022 Aug 17;19(1):206. doi: 10.1186/s12974-022-02565-0. J Neuroinflammation. 2022. PMID: 35978311 Free PMC article. Review.
-
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele.Brain Pathol. 2024 Jan;34(1):e13208. doi: 10.1111/bpa.13208. Epub 2023 Aug 30. Brain Pathol. 2024. PMID: 37646624 Free PMC article. Review.
-
ApoE4: an emerging therapeutic target for Alzheimer's disease.BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4. BMC Med. 2019. PMID: 30890171 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous